Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 Jun;15(6):1500-5.
doi: 10.1110/ps.062128706. Epub 2006 May 2.

The crystal structure of human receptor protein tyrosine phosphatase kappa phosphatase domain 1

Affiliations

The crystal structure of human receptor protein tyrosine phosphatase kappa phosphatase domain 1

Jeyanthy Eswaran et al. Protein Sci. 2006 Jun.

Abstract

The receptor-type protein tyrosine phosphatases (RPTPs) are integral membrane proteins composed of extracellular adhesion molecule-like domains, a single transmembrane domain, and a cytoplasmic domain. The cytoplasmic domain consists of tandem PTP domains, of which the D1 domain is enzymatically active. RPTPkappa is a member of the R2A/IIb subfamily of RPTPs along with RPTPmu, RPTPrho, and RPTPlambda. Here, we have determined the crystal structure of catalytically active, monomeric D1 domain of RPTPkappa at 1.9 A. Structural comparison with other PTP family members indicates an overall classical PTP architecture of twisted mixed beta-sheets flanked by alpha-helices, in which the catalytically important WPD loop is in an unhindered open conformation. Though the residues forming the dimeric interface in the RPTPmu structure are all conserved, they are not involved in the protein-protein interaction in RPTPkappa. The N-terminal beta-strand, formed by betax association with betay, is conserved only in RPTPs but not in cytosolic PTPs, and this feature is conserved in the RPTPkappa structure forming a beta-strand. Analytical ultracentrifugation studies show that the presence of reducing agents and higher ionic strength are necessary to maintain RPTPkappa as a monomer. In this family the crystal structure of catalytically active RPTPmu D1 was solved as a dimer, but the dimerization was proposed to be a consequence of crystallization since the protein was monomeric in solution. In agreement, we show that RPTPkappa is monomeric in solution and crystal structure.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
(A) Structure-based sequence alignment of RPTPκ, RPTPλ, RPTPρ, and RPTPμ (PDB codes: RPTPμ, 1RPM; RPTPκ, 2C7S). Secondary structure elements were determined using the program ICM (Molsoft) using the nomenclature in (Barford et al. 1994). (Red) α-Helices; (green) β-strands; (magenta) 310-helices. The asterisks indicate residues involved in dimerization in the R2A/IIb subfamily of receptor protein tyrosine phosphatases. (B) Sedimentation coefficient distribution for 1.2 mg/mL RPTPκ in 10 mM HEPES, 25 mM NaCl (pH 7.5) (red), and 50 mM HEPES, 150 mM NaCl, 5 mM DTT (blue). (C) Molecular weight distribution for 1.2 mg/mL RPTPκ in 10 mM HEPES, 25 mM NaCl (pH 7.5) (red), and 50 mM HEPES, 150 mM NaCl, 5 mM DTT (blue).
Figure 2.
Figure 2.
Three-dimensional structure of RPTPκ. (Red) α-Helices; (green) β-strands; (magenta) 310-helices. The helix-turn-helix segment (α1′, α2′) and the β-strand formed by association of βx and βy are labeled. The corresponding conserved residues involved in dimerization of RPTPμ are shown in ball-and-stick representation.

Similar articles

Cited by

References

    1. Alonso A., Sasin J., Bottini N., Friedberg I., Friedberg I., Osterman A., Godzik A., Hunter T., Dixon J., Mustelin T. 2004. Protein tyrosine phosphatases in the human genome Cell 117 699–711. - PubMed
    1. Andersen J.N., Mortensen O.H., Peters G.H., Drake P.G., Iversen L.F., Olsen O.H., Jansen P.G., Andersen H.S., Tonks N.K., Moller N.P. 2001. Structural and evolutionary relationships among protein tyrosine phosphatase domains Mol. Cell. Biol. 21 7117–7136. - PMC - PubMed
    1. Barford D., Flint A.J., Tonks N.K. 1994. Crystal structure of human protein tyrosine phosphatase 1B Science 263 1397–1404. - PubMed
    1. Bilwes A.M., den Hertog J., Hunter T., Noel J.P. 1996. Structural basis for inhibition of receptor protein–tyrosine phosphatase-α by dimerization Nature 382 555–559. - PubMed
    1. Desai D.M., Sap J., Schlessinger J., Weiss A. 1993. Ligand-mediated negative regulation of a chimeric transmembrane receptor tyrosine phosphatase Cell 73 541–554. - PubMed

Publication types

Substances

Associated data

LinkOut - more resources